**Question:** Which of the following statements regarding ACE inhibitor is true:

A. ACE inhibitors reduce blood pressure by blocking the renin-angiotensin-aldosterone system (RAAS)
B. ACE inhibitors primarily affect the cardiovascular system
C. ACE inhibitors are contraindicated in patients with severe kidney impairment
D. ACE inhibitors are only used in patients with heart failure

**Core Concept:** ACE inhibitors are a class of medications commonly used in the treatment of hypertension, heart failure, and diabetic nephropathy. They function by inhibiting the angiotensin-converting enzyme (ACE), which results in a decrease in the production of angiotensin II. Angiotensin II is a potent vasoconstrictor that contributes to the maintenance of blood pressure and the progression of kidney disease. By blocking the RAAS (renin-angiotensin-aldosterone system), ACE inhibitors exert their beneficial effects on the cardiovascular system and renal function.

**Why the Correct Answer is Right:** ACE inhibitors are indeed effective in reducing blood pressure by blocking the RAAS. This leads to vasodilation, decreased aldosterone secretion, and reduced sodium and water retention, ultimately lowering blood pressure.

**Why Each Wrong Option is Incorrect:**

A. ACE inhibitors primarily affect the cardiovascular system, not just the RAAS. They also have renal benefits by reducing proteinuria and slowing down the progression of kidney disease.
B. ACE inhibitors are not only used in patients with heart failure. They are also prescribed for hypertension and diabetic nephropathy.
C. ACE inhibitors are not contraindicated in patients with severe kidney impairment. In fact, they can slow down the progression of kidney disease and improve outcomes in patients with chronic kidney disease and hypertension.
D. ACE inhibitors are not only used in patients with heart failure. They are also prescribed for hypertension and diabetic nephropathy.

**Clinical Pearl:** ACE inhibitors are a cornerstone of treatment for various medical conditions, including hypertension, heart failure, and diabetic nephropathy. Their renin-angiotensin-aldosterone system inhibition leads to benefits beyond blood pressure reduction, such as renal protection and improved cardiovascular outcomes.